Targeted synovial fluid proteomics for biomarker discovery in rheumatoid arthritis

Clinical Proteomics

Volumn 5, Issue 2, 2009, Pages 75-102

  Cano, Leticia ^a,c   Arkfeld, Daniel G ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Autoantibodies; Autoantigens; Autoimmune disease; Biomarker discovery; Citrullination; Clinical proteomics; ELISA, protein macroarrays; Fibrinogen; Mass spectrometry; Post translational modification; Rheumatoid arthritis; Synovial fluid

Indexed keywords

ARGININE; AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; CITRULLINE; FIBRIN; PROTEIN;

ACETYLATION; AMINO ACID SEQUENCE; ARTICLE; CHROMATOFOCUSING; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN MICROARRAY; PROTEIN PROCESSING; PROTEOMICS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM;

EID: 70349596828     PISSN: 15426416     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12014-009-9028-1     Document Type: Article

References (49)

1. M Feldmann FM Brennan RN Maini 1996 Rheumatoid arthritis Cell 85 307 310 8616886 10.1016/S0092-8674(00)81109-5 1:CAS:528:DyaK28XivVyrs7w%3D (Pubitemid 26160702)
2. GS Firestein 2003 Evolving concepts of rheumatoid arthritis Nature 423 6937 356 361 12748655 10.1038/nature01661 1:CAS:528:DC%2BD3sXjs1ynu7c%3D (Pubitemid 40852711)
3. VM Corrigall GS Panayi 2002 Autoantigens and immune pathways in rheumatoid arthritis Crit Rev Immunol 22 4 281 293 12678429 1:CAS:528: DC%2BD3sXjtVyrtbc%3D
4. MAv Boekel, et al. 2002 Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value Arthritis Rheum 4 87 93
5. Fv Gaalen, et al. 2005 The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis J Immunol 175 5575 5580 16237041
6. G Firestein 2005 Immunologic mechanisms in the pathogenesis of rheumatoid arthritis J Clin Rheumatol 11 S39 S44 16357749 10.1097/01.rhu.0000166673.34461. 33 (Pubitemid 40863818)
7. PJ Utz TJ Gensler P Anderson 2000 Death, autoantigen modifications, and tolerance Arthritis Res Ther 2 101 114 1:CAS:528:DC%2BD3cXlslyjt7g%3D
8. ER Vossenaar WJv Venrooij 2004 Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis Arthritis Res Ther 6 107 111 15142259 10.1186/ar1184 1:CAS:528:DC%2BD2cXot1WlsrY%3D
9. P Plotz 2003 The autoantibody repertoire: searching for order Nat Rev Immunol 3 73 78 12511877 10.1038/nri976 1:CAS:528:DC%2BD3sXovVI%3D (Pubitemid 37328701)
10. GA Schellekens, et al. 1998 Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies J Clin Invest 101 273 281 9421490 10.1172/JCI1316 1:CAS:528:DyaK1cXjtFSjsg%3D%3D
11. S Rantapää-Dahlqvist, et al. 2003 Antibodies against cyclic citrullinated peptide and iga rheumatoid factor predict the development of rheumatoid arthritis Arthritis Rheum 48 10 2741 2749 14558078 10.1002/art.11223 (Pubitemid 37280601)
12. MMJ Nielen, et al. 2004 Specific autoantibodies precede the symptoms of rheumatoid arthritis Arthritis Rheum 50 2 380 386 14872479 10.1002/art.20018 (Pubitemid 38198821)
13. K Lundberg, et al. 2005 Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity Arthritis Res Ther 7 R458 R467 15899032 10.1186/ar1697 1:CAS:528:DC%2BD2MXivVygsLo%3D
14. AHvdH-v Mil, et al. 2005 Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis Arthritis Res Ther 7 R949 R958 10.1186/ar1767
15. A Suzuki R Yamada X Chang S Tokuhiro, et al. 2003 Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis Nat Genet 34 395 402 12833157 10.1038/ng1206 1:CAS:528:DC%2BD3sXmt1SkurY%3D (Pubitemid 36935332)
16. E Tarcsa, et al. 1996 Protein unfolding by peptidylarginine deiminase J Biol Chem 271 48 30709 30716 8940048 10.1074/jbc.271.48.30709 1:CAS:528:DyaK28XntlaksLk%3D (Pubitemid 26404088)
17. C Masson-Bessière, et al. 2001 The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the a- and b-chains of fibrin J Immunol. 166 4177 4184 11238669
18. K Skriner, et al. 2006 Association of citrullinated proteins with synovial exosomes Arthritis Rheum 54 12 3809 3814 17133577 10.1002/art.22276 1:CAS:528:DC%2BD2sXktlamsw%3D%3D (Pubitemid 44955881)
19. Y Takizawa, et al. 2006 Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids Ann Rheum Dis 65 1013 1020 16449316 10.1136/ard.2005.044743 1:CAS:528:DC%2BD28XosFahur0%3D (Pubitemid 44133262)
20. E Girbal-Neuhauser, et al. 1999 The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (Pro) filaggrin by deimination of arginine residues J Immunol 162 585 594 9886436 1:CAS:528:DyaK1MXjtlahsQ%3D%3D
21. M Sebbag, et al. 1995 The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantobodies J Clin Invest 95 2672 2679 7539459 10.1172/JCI117969 1:CAS:528: DyaK2MXmtV2qsL8%3D
22. ER Vossenaar, et al. 2004 Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin Arthritis Res Ther 6 R142 R150 15059278 10.1186/ar1149 1:CAS:528:DC%2BD2cXktValtLw%3D
23. H Bang, et al. 2007 Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis Arthritis Rheum 56 8 2503 2511 17665451 10.1002/art.22817 1:CAS:528:DC%2BD2sXhtVWqu7rK (Pubitemid 47237269)
24. K Tilleman, et al. 2008 Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides Rheumatology (Oxford) 47 5 597 604 10.1093/rheumatology/ken077 1:CAS:528:DC%2BD1cXkvFymtrw%3D (Pubitemid 351619196)
25. A Suzuki, et al. 2005 Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis Biochem Biophys Res Commun 333 418 426 15950180 10.1016/j.bbrc.2005.05.137 1:CAS:528:DC%2BD2MXlsVChtbk%3D (Pubitemid 40848307)
26. MK Koivula, et al. 2008 Sensitivity and specificity of autoantibodies binding to citrullinated carboxyterminal telopeptides of types I and II collagens in an early arthritis series Rheumatology (Oxford) 47 5 656 659 10.1093/rheumatology/ken092 1:CAS:528:DC%2BD1cXkvFymtr4%3D (Pubitemid 351619208)
27. H Burkhardt, et al. 2005 Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis Eur J Immunol 35 1643 1652 15832289 10.1002/eji.200526000 1:CAS:528:DC%2BD2MXksVKntLY%3D (Pubitemid 40691444)
28. M Yoshida, et al. 2006 Autoimmunity to citrullinated type II collagen in rheumatoid arthritis Mod Rheumatol 16 5 276 281 17039307 10.1007/s10165-006- 0498-y 1:CAS:528:DC%2BD28XhtVOmu7vP (Pubitemid 44575252)
29. X Chang, et al. 2005 Citrullination of fibronectin in rheumatoid arthritis synovial tissue Rheumatology 44 11 1374 1382 16105911 10.1093/rheumatology/kei023 1:CAS:528:DC%2BD2MXhtFCjtL7M (Pubitemid 41631860)
30. A Kinloch, et al. 2005 Identification of citrullinated α-enolase as a candidate autoantigen in rheumatoid arthritis Arthritis Res Ther 7 R1421 R1429 16277695 10.1186/ar1845 1:CAS:528:DC%2BD2MXht1Wmsr%2FL
31. W Hueber WH Robinson 2006 Proteomic biomarkers for autoimmune disease Proteomics 6 4100 4115 16786488 10.1002/pmic.200600017 1:CAS:528: DC%2BD28XnvFaltr4%3D
32. F Yan, et al. 2003 Protein microarrays using liquid phase fractionation of cell lysates Proteomics 3 1228 1235 12872223 10.1002/pmic.200300443 1:CAS:528:DC%2BD3sXmtF2rsbY%3D (Pubitemid 36929544)
33. FC Arnett, et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 3 315 324 3358796 10.1002/art.1780310302 1:STN:280:DyaL1c7pt1Ohsg%3D%3D
34. MC Hochberg, et al. 1992 The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis Arthritis Rheum 35 5 498 502 1575785 10.1002/art.1780350502 1:STN:280:DyaK383kslSntg%3D%3D
35. DD Smith, et al. 2006 Median filter algorithm for estimating the threshold of detection on custom protein arrays Biotechniques 41 74 78 16869517 10.2144/000112204 1:CAS:528:DC%2BD28XmvVGqurc%3D (Pubitemid 46534906)
36. JRd Yates J Eat AL McCormack D Schieltz 1995 Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database Anal Chem 67 1426 1436 7741214 10.1021/ac00104a020 1:CAS:528: DyaK2MXksVymt7g%3D
37. EI Chen, et al. 2006 Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT) Mol Cell Proteomics 5 53 56 16272560 1:CAS:528:DC%2BD28Xms1arsA%3D%3D
38. N Rifai MA Gillette SA Carr 2006 Protein biomarker discovery and validation: the long and uncertain path to clinical utility Nat Biotechnol 24 8 971 983 16900146 10.1038/nbt1235 1:CAS:528:DC%2BD28XnvVygtL8%3D (Pubitemid 44215392)
39. W Zolg 2006 The proteomic search for diagnostic biomarkers: lost in translation? Mol Cell Proteomics 5 10 1720 1726 16546995 10.1074/mcp.R600001- MCP200 1:CAS:528:DC%2BD28XhtFGqsbnL (Pubitemid 44688184)
40. X Chang R Yamada A Suzuki T Sawada S Yoshino S Tokuhiro K Yamamoto 2005 Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis Rheumatology (Oxford) 44 1 40 50 10.1093/rheumatology/keh414 1:CAS:528:DC%2BD2MXisVSqsw%3D%3D (Pubitemid 40124330)
41. M Nakayama-Hamada, et al. 2005 Comparison of enzymatic properties between hPADI2 and hPADI4 Biochem Biophys Res Commun 327 192 200 15629448 10.1016/j.bbrc.2004.11.152 1:CAS:528:DC%2BD2MXksFCq (Pubitemid 40051370)
42. 18O stable isotope labeling and mass spectrometry Rapid Commun Mass Spectrom 19 683 688 15700232 10.1002/rcm.1842 1:CAS:528:DC%2BD2MXitFyiu7c%3D (Pubitemid 40332764)
43. W Hueber, et al. 2005 Antigen microarray profiling of autoantibodies in rheumatoid arthritis Arthritis Rheum 52 9 2645 2655 16142722 10.1002/art.21269 1:CAS:528:DC%2BD2MXhtFeltrvF (Pubitemid 41369092)
44. M Sebbag, et al. 2006 Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins Eur J Immunol 36 2250 2263 16838278 10.1002/eji.200535790 1:CAS:528: DC%2BD28XovFGgu7w%3D (Pubitemid 44251769)
45. A Sinz, et al. 2002 Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis Electrophoresis 23 3445 3456 12373775 10.1002/1522-2683(200210)23:19<3445::AID-ELPS3445>3.0.CO;2-J 1:CAS:528:DC%2BD38Xot1Kis7s%3D (Pubitemid 35230230)
46. O Sánchez-Pernaute, et al. 2003 A fibrin based model for rheumatoid synovitis Ann Rheum Dis 62 1135 1138 14644849 10.1136/ard.2003.011767 (Pubitemid 37500617)
47. AH Henschen-Edman 2001 Fibrinogen non-inherited heterogeneity and its relationship to function in health and disease Annals NY Acad Sci 936 580 593 1:CAS:528:DC%2BD3MXlsV2rtL0%3D
48. D Scott 2004 Radiological progression in established rheumatoid arthritis J Rheumatol Suppl 69 55 65 15053455
49. FAv Gaalen, et al. 2004 Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis Arthritis Rheum 50 3 709 715 15022309 10.1002/art.20044 (Pubitemid 38326168)